JUPITER NEUROSCIENCES INC
JUNSNASDAQTrading Snapshot
- Day Range
- $4.86 – $4.98
- 52-Week Range
- $4.60 – $138.00
- Volume
- $1.69B
- Avg Volume
- $1.68B
- Shares Outstanding
- 484,666
- Next Earnings
- Oct 25, 2026
Fundamentals Snapshot
- Annual Revenue
- $21,796
- Last Q Revenue
- $18,652
- P/E Ratio
- -0.2
- P/S Ratio
- 59.0x
- EPS (TTM)
- $-19.52
- Dividend Yield
- 0.00%
Why Investors Own JUNS
- ✓High-growth profile — revenue up -1.1% YoY with expanding US Equity exposure.
- ✓Healthy economics — 27% gross margin and 29% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About JUPITER NEUROSCIENCES INC
Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in clinical-stage research and development. Its primary focus is on advancing a resveratrol-based platform product, with the main objective of addressing neuro-inflammation. The company's pipeline includes several drug candidates: JNS101 is undergoing Phase II trials for Friedreich's Ataxia, a rare neurological disorder that damages the nervous system and causes mobility issues. Also in Phase II, JNS102 is being developed for mucopolysaccharidosis Type I, JNS107 for MELAS Syndrome, and JNS108 for mild cognitive impairment and early Alzheimer's disease. Furthermore, the company is progressing JNS109 for amyotrophic lateral sclerosis, JNS110 for traumatic brain injury and concussion, and JNS120 as a treatment for COVID-19. Founded in 2016, the company, formerly known as Jupiter Orphan Therapeutics, Inc., adopted its current name in August 2021 and is headquartered in Jupiter, Florida.
Otter Score Breakdown
ⓘAnalyst Ratings
ⓘLatest News & Updates
Gapping stocks in Wednesday's session
The market is filled with gapping stocks in Wednesday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Discover the top movers in Wednesday's pre-market session.
Before the opening bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards by 43.0% to $1.43 during Wednesday's pre-market session. The company's market cap stands at $1.0 million. Estrella Immunopharma (NASDAQ:ESLA)
Jupiter Neurosciences Announces 1-For-75 Reverse Stock Split, Effective Aug. 6
Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter" or the "Company"), a clinical-stage biopharmaceutical company focused on developing innovative therapies for neurological and neurodegenerative
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Tenet Healthcare (NYSE:THC) stock increased by 17.3% to $233.54 during Friday's regular session. The market value of their outstanding shares is at $17.4 billion. The company's, Q2 earnings came out
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers NovoCure (NASDAQ:NVCR) shares moved upwards by 27.7% to $19.88 during Thursday's regular session. The market value of their outstanding shares is at $1.8 billion. The company's, Q2 earnings came out